SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal AntibodiesEditorial Published on 2021-06-232022-10-28 Journal: Viruses [Category] [DOI] 10.3390/v13071211 PMC 바로가기 [Article Type] Editorial
Emergent Inpatient Administration of Casirivimab and Imdevimab Antibody Cocktail for the Treatment of COVID-19 PneumoniaInternal Medicine Published on 2021-05-272022-10-31 Journal: Cureus [Category] [DOI] 10.7759/cureus.15280 PMC 바로가기 [Article Type] Internal Medicine
The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomizationUPMC OPTIMISE-C19(COVID-19에 대한 평가를 통한 단일 클론 항체의 치료 및 영향 최적화) 시험: 반응 적응형 무작위 배정이 포함된 개방형, 실용적, 비교 효과 플랫폼 시험을 위한 연구 프로토콜의 구조화된 요약Letter Published on 2021-05-252022-09-01 Journal: Trials [Category] [DOI] 10.1186/s13063-021-05316-3 PMC 바로가기 [Article Type] Letter
The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 PseudovirusSARS-CoV-2 계통 B.1.351 슈도바이러스의 감염성 및 중화 효율에 미치는 영향Communication Published on 2021-04-072022-09-01 Journal: Viruses [Category] [DOI] 10.3390/v13040633 PMC 바로가기 [Article Type] Communication
Neutralizing Antibody Therapeutics for COVID-19COVID-19에 대한 중화 항체 치료제Review Published on 2021-04-072022-09-01 Journal: Viruses [Category] [DOI] 10.3390/v13040628 PMC 바로가기 [Article Type] Review
Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemicCOVID-19 전염병 동안 접근 프로그램 확대, 동정적 약물 사용 및 긴급 사용 승인Review Published on 2021-02-012022-09-11 Journal: Drug discovery today [Category] [DOI] 10.1016/j.drudis.2020.11.025 PMC 바로가기 [Article Type] Review
Initial Guidance on Use of Monoclonal Antibody Therapy for Treatment of COVID-19 in Children and AdolescentsArticle Published on 2021-01-032023-07-02 Journal: Journal of the Pediatric Infectious Diseases Socie [Category] [DOI] 10.1093/jpids/piaa175 PMC 바로가기
Influence of Social and Cultural Factors on the Decision to Consent for Monoclonal Antibody Treatment among High-Risk Patients with Mild-Moderate COVID-19경증-중등도 COVID-19 고위험군 환자의 단클론항체 치료 동의 결정에 대한 사회적, 문화적 요인의 영향Article Published on 2021-01-012022-09-12 Journal: Journal of primary care & community health [Category] [DOI] 10.1177/21501327211019282 PMC 바로가기 [Article Type] Article